Porphyrin-polyamine conjugates for cancer therapy
US7026347B2 · kind B2 · utility
11Cited by
8References
16Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jun 24, 2003 |
| Grant date | Apr 11, 2006 |
| Priority date | — |
| Expiry date | Jun 24, 2023 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P35/00
- WIPO fieldOrganic fine chemistry
- WIPO sectorChemistry
Abstract
Porphyrin-polyamine conjugate compounds are disclosed which have anticancer and antitumor effects. The porphyrin moiety selectively localizes in tumors, while the polyamine moiety serves as a cytotoxic agent. Methods of making and using the porphyrin-polyamine conjugate compounds are also disclosed.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.